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. Discrete subsets of immune cells integrate nervous system cues 2-4 , but it remains unclear whether neuron-derived signals control ILC2s. Here we show that neuromedin U (NMU) in mice is a fast and potent regulator of type 2 innate immunity in the context of a functional neuron-ILC2 unit. We found that ILC2s selectively express neuromedin U receptor 1 (Nmur1), and mucosal neurons express NMU. Cell-autonomous activation of ILC2s with NMU resulted in immediate and strong NMUR1-dependent production of innate inflammatory and tissue repair cytokines. NMU controls ILC2s downstream of extracellular signal-regulated kinase and calcium-influx-dependent activation of both calcineurin and nuclear factor of activated T cells (NFAT). NMU treatment in vivo resulted in immediate protective type 2 responses. Accordingly, ILC2-autonomous ablation of Nmur1 led to impaired type 2 responses and poor control of worm infection. Notably, mucosal neurons were found adjacent to ILC2s, and these neurons directly sensed worm products and alarmins to induce NMU and to control innate type 2 cytokines. Our work reveals that neuron-ILC2 cell units confer immediate tissue protection through coordinated neuroimmune sensory responses.
ILC2s are abundant at mucosal barriers and act as key initiators of type 2 inflammation and tissue repair 1 . ILC2s are activated by cell-extrinsic cytokines, including interleukin 25 (IL-25), IL-33 and thymic stromal lymphopoietin (TSLP) 1 . Previous reports indicated that discrete lymphocyte subsets and haematopoietic progenitors are controlled by dietary signals and neuroregulators 2, [4] [5] [6] [7] [8] [9] [10] [11] , suggesting that ILC2s may exert their function in the context of neuroimmune cell units 4 . To investigate whether ILC2s directly and selectively perceive neuronal-derived molecules, we used genome-wide transcriptional profiling of ILC2s to compare them to their adaptive (T helper cells) and innate (ILC1 and ILC3) counterparts 12 ( Fig. 1a, b ). This analysis identified the gene Nmur1 as being selectively enriched in ILC2s when compared to ILC1s, ILC3s and T helper cells (Fig. 1a, b , Extended Data Fig. 1a, b) . This finding was confirmed by independent quantitative expression assays in multiple subsets of immune cells, including ILC1s, ILC3s, natural killer cells, eosinophils, mast cells, macrophages, neutro phils, dendritic cells, T cell subsets and B cells (Fig. 1c, Extended Data Fig. 1c, d) . Notably, human ILC2 also expressed NMUR1 (Fig. 1d) . This gene encodes a transmembrane receptor for NMU. The latter is a secreted neuropeptide found in the brain and highly expressed in the gastrointestinal tract [13] [14] [15] [16] . As such, NMU acts as a neuronal-derived regulator in diverse physiologic processes 16 . NMU was shown to be produced by cholinergic enteric neurons, which also express the neurotrophic factor receptor RET [13] [14] [15] 17 . In agreement, the NMU gene (Nmu) was mainly expressed by neurons in the lamina propria, whereas these transcripts were not detectable in enteric neuroglia and epithelial cells (Fig. 1e) . Similarly, all analysed immune cell subsets, including dendritic cells, macrophages and B cells, had no significant Nmu expression (Fig. 1e , Extended Data Fig. 1e) . Notably, the use of reporter mice for total neurons (Ret GFP ) or for cholinergic neurons (Chat-cre-Rosa26 RFP ) [18] [19] [20] revealed that CD3 − KLRG1 + candidate ILC2s are adjacent to the intestinal neuronal network (4.716 μm ± 0.656 (mean ± s.e.m.)), and lung ILC2s could also be found in the vicinity of local neurons (Fig. 1f , g, Extended Data Fig. 1f-h ). Taken together, these data suggest a paracrine neuron-ILC2 crosstalk that is orchestrated by NMU-NMUR1 interactions.
To explore this hypothesis, intestine-and lung-derived ILC2s were purified and activated with recombinant mouse peptide NMU (NmU23) (Fig. 2a-e) . Interestingly, cell-autonomous activation of ILC2s with NmU23 resulted in prompt and potent expression of the pro-inflammatory and tissue-protective type 2 cytokines genes Il5, Il13, amphiregulin (Areg) and colony stimulating factor 2 (Csf2) (Fig. 2a, b , Extended Data Fig. 2a ). NmU23-dependent activation of ILC2s also increased ILC2 proliferation, as measured by Ki67 expression (Extended Data Fig. 2b-d) . NMU was shown to bind with similar affinity to two orphan class A G-protein-coupled receptors 16 , NMUR1 and NMUR2. Genetic ablation of Nmur1 showed that NMUR1 activation provides the molecular link between NMU-dependent ILC2 activation and cytokine production. Activation of purified ILC2s with NmU23 led to potent expression of the type 2 cytokine proteins IL-5 and IL-13 in an NMUR1-dependent manner (Fig. 2c, d , Extended Data Fig. 2e-h) . Notably, and in contrast to the canonical ILC2-activating cytokines (IL-33 and IL-25), NmU23 led to an immediate strong expression of innate IL-5, IL-13 and AREG, indicating that NMU is a uniquely fast and potent regulator of ILC2-derived type 2 cytokines (Fig. 2e, Extended Data Fig. 3a, b) . In agreement, in vivo administration of the neuropeptide NmU23 resulted in immediate and selective type 2 cytokine production from ILC2s, whereas their adaptive T-helpercell-derived counterparts were unperturbed (Fig. 2f , g, Extended Data Fig. 3c ). Although NMU restored ILC2 numbers in vivo in the absence of IL-33 and IL-25 receptor signals, this neuropeptide failed to efficiently induce innate cytokines in the similar contexts (Extended Data Fig. 4a-d ). This suggests that NMU signals immediately trigger innate type 2 cytokines, whereas the canonical IL-25-IL-33 signalling axis regulates ILC2 homeostasis and function with comparatively delayed kinetics (Extended Data Fig. 4a-d) . To establish the link between ILC2-autonomous NMUR1 activation and innate type 2 cytokine production, we generated mixed bone marrow chimaeras with Nmur1-sufficient and -deficient bone marrow progenitors. Whereas NMUR1 signals were dispensable for ILC2 homeostasis (Extended Data Fig. 5a-f) , an intact NMU-NMUR1 axis was critical for production of ILC2-derived cytokines. Notably, NmU23 administration to bone marrow chimaeras revealed that Nmur1-deficient ILC2s had reduced innate IL-5 and IL-13 expression as compared to Nmur1-sufficient counterparts (Fig. 2h, i) . In contrast, T-helper-cell-derived cytokines were unperturbed in Nmur1-deficient cells (Extended Data Fig. 5g, h ). These data indicate that NMU is a rapid and potent cell-autonomous regulator of innate type 2 inflammatory and tissue repair cytokines, through NMUR1 activation.
To further examine how NMU controls innate type 2 responses, we investigated the signalling cues provided by activated NMUR1 in ILC2s. In neurons, activation of NMU receptors leads to increased Ca 2+ influx and extracellular signal-related kinase (ERK)1/2 activation, whereas NFAT activity is required for type 2 cytokine production [21] [22] [23] . Stimulation of ILC2s with NMU led to immediate and efficient ERK1/2 activation, whereas inhibition of ERK activity upon NmU23-induced ILC2 activation resulted in impaired type 2 cytokine gene expression (Fig. 3a, b) . Analysis of NMU-induced activation of ILC2s also led to immediate and robust Ca 2+ influx, suggesting a role for the calcium-dependent serine/threonine protein phosphatase calcineurin in NmU23-induced type 2 responses (Fig. 3c) . Accordingly, inhibition of calcineurin upon NmU23 activation led to impaired innate Il5, Il13 and Csf2 expression, whereas NmU23 activation led to rapid NFAT nuclear translocation in ILC2s (Fig. 3d-f, Extended Data Fig. 6 ). Finally, inhibition of NFAT activity on NmU23-induced NMUR1 activation led to a similar decrease in Il5, Il13 and Csf2 expression (Fig. 3g) . Thus, we conclude that the . Notably, infection of wild-type mice with N. brasiliensis resulted in strongly increased and sustained Nmu expression in infected tissues (Fig. 4a) , whereas expression of high levels of Nmur1 was still restricted to ILC2 (Extended Data Fig. 7a, b ). These observations suggest that NMU may regulate in vivo responses to worm infection. Accordingly, administration of the neuropeptide NmU23 in mice infected with N. brasiliensis resulted in a robust and selective ILC2 response (Fig. 4b, Extended Data Fig. 7c, d ), decreased tissue haemorrhage (Fig. 4c , Extended Data Fig. 7e , f) with subsequent increased eosinophil and mast cell infiltrates in the lung, and reduced infection burden when compared to their vehicle (PBS)-treated counterparts (Fig. 4d, e) . To further explore the role of NMUR1 in innate type 2 responses, we infected Nmur1-deficient mice and their wild-type littermate controls with N. brasiliensis ( Fig. 4f-i) . When compared to their wild-type littermate counterparts, Nmur1-deficient mice had decreased type 2 responses, notably reduced ILC2-derived cytokines (Fig. 4f, Extended Data Fig.  8a ), increased tissue haemorrhage (Fig. 4g, Extended Data Fig. 8b, c) and impaired eosinophil and mastocyte infiltrates (Fig. 4h) . In line with these findings, Nmur1-deficient mice had increased N. brasiliensis infection burden at the peak of lung and gut infection phases, whereas late worm expulsion was intact (Fig. 4i, Extended Data Fig. 8d ). To more specifically define the link between ILC2, the NMU-NMUR1 signalling axis and protection against worm infection, we generated chimaeras of Nmur1-sufficient and Nmur1-deficient ILC2s in alymphoid host mice. Infection of such chimaeras with N. brasiliensis revealed that Nmur1-knockout ILC2s had decreased type 2 cytokine responses compared to their wild-type counterparts (Fig. 4j) . Accordingly, influx, represented by Fluo-4-AM intensity. NmU23 was added 60 s after ILC2 baseline acquisition (arrow). Right, mean intensity of Ca 2+ influx (n = 3). d, Il5, Il13 and Csf2 expression in ILC2s cultured with medium (control), NmU23 or NmU23 and calcineurin inhibitor FK506 (n = 12). e, Nuclear translocation of NFAT (red) upon NmU23 activation in ILC2s. f, Left, percentage of ILC2s with nuclear NFAT (n = 3). Right, NFAT nuclear fluorescence intensity. Control (n = 16), NmU23 (n = 7), P+I (n = 8). g, Il5, Il13 and Csf2 expression in ILC2s cultured with medium (control), NmU23 or NmU23 and NFAT inhibitor 11R-VIVIT (n = 6). Scale bars, 5 μm. Data are representative of 2-4 independent experiments. Error bars show s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant.
Nmur1-deficient ILC2-chimaeras had increased N. brasiliensis infection burden (Fig. 4k) . Thus, we conclude that NMU regulates innate type 2 responses to provide immediate mucosal protection against early phases of worm infection. To test whether enteric neurons support innate type 2 cytokine production, we generated neurosphere-derived neuronal organoids (Fig. 4l ). Neuronal stimulation with the alarmin IL-33 or N. brasiliensis excretory/secretory products (NES) efficiently induced neuron-derived Nmu (Fig. 4m ). In line with this, stimulation of ILC2s with NES-activated neuronal supernatants increased expression of innate type 2 cytokines, and intranasal challenge with NES led to similar increases of ILC2-derived cytokines in the lung (Extended Data Fig. 9a, b ). Enteric neurons have been previously shown to express Toll-like receptors 2, 4 . Activation of neuronal organoids with NES or IL-33 induced Nmu expression in an MYD88-dependent manner (Fig. 4m) . To demonstrate the physiological importance of MYD88-dependent neuronal sensing in ILC2 function, we deleted Myd88 in cholinergic neurons by breeding Chat-Cre to Myd88 fl/fl mice. Notably, cholinergic-neuron-intrinsic deletion of Myd88 resulted in impaired cytokine-producing ILC2s during N. brasiliensis infection (Fig. 4n) . Taken together, these data indicate that neurons can orchestrate innate type 2 cytokines through direct sensing of worm products and alarmins.
Determining the mechanisms by which ILC2s perceive, integrate and respond to environmental signals is critical for understanding tissue and organ homeostasis. In our work, we establish unexpected relationships between ILC2s and their environment and identify a neuron-ILC2 cell unit orchestrated by NMU (Extended Data Fig. 10 ). Mucosal neurons can directly sense alarmin and worm products to produce NMU. NMU activates ILC2s, via NMUR1, resulting in potent and immediate production of innate type 2 cytokine downstream of ERK phosphorylation and activation of a Ca 2+ -calcineurin-NFAT signalling cascade (Extended Data Fig. 10 ).
Although it is well established that ILC2s integrate cytokine signals, including IL-25, IL-33 and TSLP 1, 11 , here we demonstrate that ILC2s can integrate signals from different germ-layer-derived tissues to immediately trigger inflammatory and tissue repair type 2 responses. Thus, neuron-ILC2 cell units might be poised to confer immediate tissue protection through coordinated neuroimmune sensory responses (Extended Data Fig. 10 ). Afferent extrinsic nervous cues might also affect local neuroimmune cell units, but future studies using emergent technology platforms 2, 4 are required to interrogate these putative interactions.
Previous studies demonstrated that ILC2s contribute to multiple homeostatic processes, including nutrient sensing, metabolism, tissue repair and infection control 1, 11, [24] [25] [26] [27] [28] . Here we show that NMU is the molecular link between neuronal sensing, innate type 2 responses and mucosal protection. Coupling neuronal activity and ILC2-dependent immune regulation may have ensured potent, efficient and integrated multi-tissue responses to environmental challenges throughout evolution. Notably, coordinated NMU-induced smooth muscle contraction 16 and type 2 innate immunity may have coevolved to control worms that have been intimate evolution partners of mammals. In line with this hypothesis, NMU is highly conserved across mammalian, amphibian, avian and fish species 16 . Finally, our current data and other independent studies indicate that the mucosal nervous system partners with immune cells to ensure local tissue regulation 2, 3, 29, 30 ; thus, it is tempting to speculate that neuroimmune sensory units regulate physiology and homeostasis at an organismic level. 
Fold change to control Figure 4 | Neuron-derived NMU sets ILC2-autonomous protection against worm infection. a, Nmu expression in total lung and gut after infection. Lung (n = 3), gut (n = 6). b, Lung ILC2s at day 1 after infection in NmU23 treated and control animals (n = 5). c, Left, lung haemorrhage; right, haematoxylin and eosin (H&E) lung sections at day 2 after infection. d, Eosinophil and mast cell frequencies in the bronchoalveolar lavage (BAL) at day 6 after infection (n = 5). e, N. brasiliensis infection burden in: lung phase (n = 5), intestinal phase (n = 5). f-i, Nmur1
−/− and their Nmur1 +/+ littermate controls were infected with N. brasiliensis. f, Lung ILC2s at day 6 after infection. Nmur1 +/+ (n = 6), Nmur1 −/− (n = 8). g, H&E lung sections 2 days after infection. h, Eosinophil and mast cell frequencies in the BAL at day 6 after infection. Nmur1
. j, k. Nmur1 −/− and Nmur1 +/+ wild-type littermate control ILC2 chimaeras. j, Lung ILC2.
. l, Neurospherederived neuronal organoids. m, Neuron activation with NES, LPS and IL-33. Wild type: NES (n = 12), LPS (n = 18), IL-33 (n = 17). Myd88 −/− : NES (n = 10), LPS (n = 15), IL-33 (n = 12). n, Myd88
WT/fl (n = 3), ChatCre-Myd88 fl/fl (n = 6). Scale bar, 50 μm. Data are representative of 1-3 independent experiments. Error bars show s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant. reviewer Information Nature thanks R. Maizels and the other anonymous reviewer(s) for their contribution to the peer review of this work. 34, 35 and their wild-type controls were on a BALB/c background and were bred and maintained at École Polytechnique Fédérale de Lausanne (EPFL), Switzerland. Mice were systematically compared with co-housed littermate controls unless stated otherwise. 7-12-week-old males and females were used in this study. All animal experiments were approved by national and institutional ethical committees, respectively Direção Geral de Veterinária and Service de la Consummation et des Affaires Vétérinaires Federal (Canton Vaud, Switzerland), Champalimaud Centre for the Unknown, iMM Lisboa and EPFL ethical committees. Randomisation and blinding were not used unless stated otherwise. Power analysis was performed to estimate the number of experimental mice. Analysis of gene expression microarray data. The expression profile of 239 genes related to neural pathways was performed in mouse lymphoid cells based on the Affymetrix Mouse Gene 1.0 ST Array data set (GEO accession number GSE37448) 12 . Preprocessing of microarray data (including background correction and normalization) was performed applying the robust multiarray (RMA) method 36 , included in the Bioconductor package affy 37 for the statistical software environment R 38 . Linear models and the B (empirical Bayes) statistic were employed in differential gene expression analysis, using Bioconductor package limma 39 . Plots associated with the microarray data analyses were generated in R. In vitro and in vivo ILC2 activation. For in vitro experiments, purified lung and small intestine lamina propria ILC2s were cultured in complete RPMI (supplemented with 10% fetal bovine serum (FBS), 1% hepes, sodium pyruvate, glutamine, streptomycin and penicillin) at 37 °C. ILC2s were stimulated overnight or for 2, 4, 6 or 20 h with recombinant mouse neuromedin U 23 peptide (NmU23) (100 ng ml −1 unless stated otherwise; Phoenix Pharmaceuticals), recombinant mouse IL-25 and IL-33 (10 ng ml −1 , unless stated otherwise) (R&D Systems). Control and activated ILC2s were cultured in the presence of IL-2 and IL-7 (10 ng ml −1 ; PeproTech), unless stated otherwise. ILC2s were lysed using RLT buffer (Qiagen). For cytokine protein analysis in vitro, ILC2s were incubated with brefeldin A (eBioscience) for 2, 4, 6 or 20 h before intracellular staining. For in vivo experiments, mice were injected intraperitoneal (i.p.) with NmU23 peptide (8 μg per day) during Nippostrongylus brasiliensis infection or with a single dose of NmU23 (20 μg) and analysed after 12 h. Control mice were treated with PBS alone. For cytokine protein analysis ex vivo, ILC2s were incubated with PMA (50 ng ml 
Il17rb
−/− mice and their respective wild-type controls. Bone marrow cells were CD3-depleted using Dynabeads Biotin Binder (Thermo Fisher Scientific) according to the manufacturer's instructions. 10 6 cells of each genotype (CD45.2) were injected intravenously alone or in direct competition with a third-party wild-type competitor (CD45.1/CD45.2), in a 1:1 ratio, into non-lethally irradiated (150 Rad) NSG mice (CD45.1). Mice were analysed at 8 weeks after transplantation. ILC2 adoptive transfer. For adoptive cell transfer, small intestine ILC2s from Nmur1 −/− and Nmur1 +/+ littermate control mice were purified and expanded in vitro in supplemented RPMI in the presence of recombinant mouse IL-2, IL-7 (10 ng ml −/− Il2rg −/− recipients. Mice were infected with 400 Nippostrongylus brasiliensis larvae 1 week after ILC2 transplantation. Parasite infection. Nippostrongylus brasiliensis was maintained by monthly passages in Lewis rats as previously described 40 . Infective (iL3) worms were provided by N. Harris (EPFL, Switzerland). iL3 larvae were treated for 15 min with streptomycin and penicillin (300 U ml ; Sigma), washed with PBS and counted under a stereomicroscope. Mice were injected subcutaneously with 400 iL3 in 200 μl of sterile PBS using a 21G needle. Mice were killed at days 1, 2, 6 and 9 after infection and lungs, bronchoalveolar lavage (BAL) and small intestine were collected and analysed. Infection burden. Lung and small intestine parasite burden was quantified in minced lungs and small intestine as previously described 40 . Briefly, lungs and small intestine were placed on sterile cheesecloth and suspended in a 50 ml tube containing PBS at 37 °C for at least 4 h. Viable worms that migrate out into the bottom of the tube were counted under a stereomicroscope (steREO Lumar V12; Zeiss). Airway challenge. C57BL/6J mice were anaesthetized by inhalation of isoflurane. Mice were challenged with a single intranasal dose of Nippostrongylus brasiliensis excretory/secretory products (NES) (5 μg) (provided by N. Harris (EPFL)) or with PBS in a volume of 30 μl for 4 consecutive days. 24 h after the last challenge lung and BAL were recovered for analysis. Differentiation of naive T helper cells. Enteric naive T helper cells were purified and cultured in an anti-CD3 (2 μg ml ; Roche) and DNase I (20 U ml −1 ; Affymetrix) in complete RPMI for 30 min at 37 °C, under gentle agitation. Enteric neurons and glial cells were isolated as previously described 3, 41 . Briefly, isolated tissues were digested with Liberase TM (7.5 μg ml ; Affymetrix) in complete RPMI for 30 min at 37 °C, under gentle agitation. Digested organs were disrupted by passage through a 100-μm cell strainer (BD Biosciences). A 40-80% percoll gradient centrifugation was used for additional leukocyte purification from lung and small intestine cell suspensions. Erythrocytes from lung, small intestine and bone marrow preparations were lysed with RBC lysis buffer (eBioscience). Flow cytometry and cell sorting. For cytokine protein analysis ex vivo, cells were incubated with PMA (50 ng ml −1 ), ionomycin (500 ng ml −1 ) (Sigma) and brefeldin A (eBioscience) for 4 h before intracellular staining. Intracellular staining was performed using IC fixation/permeabilization kit (eBioscience). Cell suspensions were stained with anti-CD45 (30-F11), anti-TER119 (TER-119), TCRβ (H57-597), anti-CD3ε (eBio500A2), anti-CD19 (eBio1D3), anti-NK1.1 (PK136), anti-CD11c (N418), anti-Gr1 (RB6-8C5), anti-CD11b (Mi/70), anti-CD127 (IL-7Rα; A7R34), anti-α4β7 (DATK32), anti-Flt3 (A2F10), anti-CD25 (PC61.5), anti-c-Kit (2B8), anti-Thy1.2 (53-2.1), anti-CD49b (DX5), anti-TCRγδ (GL3), anti-NKp46 (29A1.4), anti-CD4 (GK1.5), anti-CD31 (390), anti-IL-13 (eBio13A), anti-F4/80 (BM8), anti-FcεR1 (MAR-1), anti-CD44 (IM7), anti-CD62L (MEL-14), 7AAD viability dye, anti-CD16/CD32 (93) from eBioscience; anti-CD8α (53-6.7), anti-KLRG1 (2F1/KLRG1), anti-Sca1 (D7), anti-CCR3 (J073E), anti-MHC-II (M5/114.15.2), anti-Ki67 (16A8), anti-streptavidin and anti-CD326 (G8.8) from Biolegend, anti-IL-5 (MH9A3) from BD Biosciences, anti-amphiregulin (R&D Systems). LIVE/DEAD Fixable Aqua Dead Cell Stain Kit was purchased from Invitrogen. Cell populations were defined as: common lymphoid progenitor, Lin 
+ cells, unless stated otherwise. Sorted populations were >95% pure. Data analysis was done using FlowJo software (Tristar). Enteric neurosphere-derived neurons. Enteric neurosphere-derived neurons were obtained as previously described 29 . Briefly, total intestines from embryonic day 14.5 (E14.5) to E18.5 Myd88 −/− and control embryos were digested with collagenase D (0.5 mg ml ; Affymetrix) in supplemented DMEM/F-12, GlutaMAX (1% hepes, penicillin and streptomycin and 0.1% β-mercaptoethanol) (Gibco) for 1 h at 37 °C under gentle agitation. Cells were mechanically disrupted, washed and cultured in a non-adherent plate for 1 week in a CO 2 incubator at 37 °C in supplemented DMEM/F-12, GlutaMAX with B27 (Gibco), EGF and FGF2 (20 ng ml
; R&D Systems). After neurosphere formation, cells were dissociated using NeuroCult (STEMCELL Technologies) chemical dissociation kit, according to the manufacturer's instructions. Dissociated neurospheres were plated on a 24-well plate previously coated with PDL (100 μg ml −1
; Sigma) and cultured in supplemented NEUROBASAL media (1% hepes, glutamine, penicillin and streptomycin) (Gibco) with B27 for neuronal differentiation. After 7 days, neuronal organoids were used either for activation or immunostaining. Enteric neurosphere-derived neurons were activated with LPS (5 μg ml −1 ; Invivogen), recombinant mouse IL-33 (100 ng ml
; R&D Systems) and NES (10 μg ml . Quantitative RT-PCR. Total RNA was extracted using RNeasy micro kit (Qiagen) according to the manufacturer's protocol. When indicated, total brain, lung and proximal duodenum was collected for RNA extraction using Trizol (Invitrogen) and zirconia/silica beads (BioSpec) in a bead beater (MIDSCI), according to the manufacturer's protocol. RNA concentration was determined using Nanodrop Spectrophotometer (Nanodrop Technologies). Quantitative real-time RT-PCR was performed as previously described 5, 8 . Hprt, Gapdh and Eef1a1 were used as housekeeping genes. For neurospheres-derived neurons Hprt, Gapdh, Tubb3 and Rbfox3 were used as housekeeping genes. For TaqMan assays (Applied Biosystems) RNA was retro-transcribed using a High Capacity RNA-to-cDNA Kit (Applied Biosystems), followed by a pre-amplification PCR using TaqMan PreAmp Master Mix (Applied Biosystems). TaqMan Gene Expression Master Mix (Applied Biosystems) was used in real-time PCR. TaqMan Gene Expression Assays (Applied Biosystems) were the following: Hprt Mm00446968_m1; Gapdh Mm99999915_ g1; Eef1a1 Mm01973893_g1; Il5 Mm00439646_m1; Il13 Mm00434204_m1; Areg Mm1354339_m1; Csf2 Mm01290062_m1; Gata3 Mm00484683_m1; Rora Mm01173766_m1; Nmu Mm00479868_m1; Nmur1 Mm04207994_m1; Nmur2 Mm00600704_m1; Tubb3 Mm00727586_s1 and Rbfox3 Mm01248771_m1. Realtime PCR analysis was performed using StepOne Real-Time PCR system (Applied Biosystems). For the analysis of human blood cells the TaqMan Gene Expression Assays were the following: HPRT1 Hs02800695_m1; GAPDH Hs02786624_g1; and NMUR1 Hs00173804_m1. Samples were normalized using HPRT1 and GAPDH as housekeeping genes. The mRNA analysis was done using the comparative CT method (2
−ΔCt
). When comparison or fold change between samples was required, the comparative ΔCT method (2 −ΔΔCt ) was applied. Cell signalling. Purified ILC2s from small intestine and lung were FBS starved for 2 h before in vitro activation with NmU23 at 37 °C. To test for ERK phosphorylation (Cell Signaling Technology), purified ILC2s were activated with NmU23 (100 ng ml ; Phoenix Pharmaceuticals) in the presence of IL-2 and IL-7 (10 ng ml −1 ; PeproTech) for 10 min before intracellular staining. To test ERK, calcineurin and NFAT activation, ILC2s were cultured for 1 h with their respective inhibitor and then stimulated with NmU23 overnight before mRNA expression analysis. ERK inhibitor, PD98059 (40 μM; Sigma); calcineurin inhibitor, FK506 (100 nM) and CsA (100 nM) (Tocris Bioscience); NFAT inhibitor, 11R-VIVIT (10 μM) (Tocris Bioscience). Calcium signalling. Purified ILC2s from the small intestine were cultured with IL-2 and IL-7 (10 ng ml −1 ) and FBS deprived for 6 h before calcium signalling experiments. ILC2s were stained with Fluo-4 Direct Calcium Assay Kit (Thermo Fisher Scientific) according to manufacturer's protocol. Calcium (Ca 2+ ) influx, represented by the Fluo-4 AM, was recorded over time on a BD Accuri C6 (BD Biosciences) flow cytometer as previously reported 42 . The recombinant mouse NmU23 was added 60 s after ILC2 baseline recording. Data was represented by the mean values of Ca 2+ influx kinetics between the ILC2 baseline response and the peak of response after recombinant mouse NmU23 addition. Histopathology analysis. Mice were killed by cervical dislocation. The caudal lobe of the right lung was harvested, fixed in 10% neutral buffered formalin and processed for paraffin embedding. Serial 4-μm sections were stained for haematoxylin and eosin (H&E), Luna and immunohistochemistry for myeloperoxidase (MPO) was performed. Briefly, using standard protocols, antigen heat-retrieval was performed at low pH 43 in Dako PT module, followed by incubation with the primary antibody (polyclonal rabbit anti-human Myeloperoxidase, Dako Corp). Incubation with ENVISION kit (Peroxidase/DAB detection system, Dako Corp) was followed by Harri's haematoxylin counterstaining (Bio Otica). Negative control included the absence of primary antibodies. Slides were analysed by a pathologist blinded to experimental groups and images were acquired in a Leica DM2500 microscope, coupled with a Leica MC170 HD microscope camera. Quantification of inflammatory cell infiltration of the lung was performed in MPO-stained sections by manual counting of MPO-positive cells at 20× original magnification, corresponding to 0.2 mm 2 per field. Quantification of pulmonary eosinophils was performed in Luna-stained slides by manual counting the number of granulocytes with eosinophilic granular cytoplasm in low power fields (1 mm 2 per field). Microscopy. Sections from lungs were obtained from NGS and irradiated (400 rad) Chat-Cre-Rosa26 RFP mice after reconstitution with wild-type ILC2s. Sections of small intestine were obtained from Chat-Cre-Rosa26 RFP and Ret GFP mice. Sections of 100 μm were obtained with a Leica VT1200/VT1200 S vibratome. Briefly, samples were fixed with 4% PFA at 4 °C overnight and were then incorporated in 4% low-melting temperature agarose (Invitrogen). Samples were blocked and permeabilized with PBS containing 0.6% Triton X-100 and 2% BSA and incubated for 1-2 days at room temperature with the following antibodies: mouse monoclonal anti-KLRG1 (2F1/KLRG1; Biolegend); anti-CD3 (17A2; Biolegend) and antitubulin β 3 (TUBB3) (TUJ1; Covance) for small intestine imaging and anti-Thy1.2 (53-2.1; eBioscience), anti-CD45.1 (A20; Biolegend) and anti-TUBB3 (TUJ1; Covance) for lung imaging. Alexa Fluor 647 goat anti-hamster, Alexa Fluor 568 goat anti-rat and Alexa Fluor 633 goat anti-mouse (Invitrogen) were used as secondary antibodies overnight at room temperature. Distances between neurons and ILC2 were measured using Imaris software. For NFAT2 imaging, ILC2s were sorted from small intestine of C57Bl/6J mice. ILC2s were FBS starved for 2 h and treated for 90 min with NmU23 (100 ng ml
−1
). After stimulation, cells were plated in a pre-coated 0.01% of poly-l-lysine (Sigma) coverslip and let to adhere. Cells were fixed with 2% PFA for 30 min at room temperature. Coverslips were blocked and permeabilized at room temperature for 30 min with a PBS solution containing 0.3% Triton X-100 and 1% BSA. Cells were stained at room temperature for 150 min with mouse monoclonal anti-NFAT2 antibody (7A6; Abcam). ILC2s were incubated subsequently at room temperature in the dark for 30 min with Alexa Fluor 488 goat anti-mouse antibody (Invitrogen) and then counterstained for 5 min with DAPI. For quantification of NFAT2 fluorescence intensity single-cell ILC2 nuclei were identified by DAPI staining. Regions of interest (ROIs) were defined from each cell nucleus and NFAT signal was measured using ImageJ software. Enteric neurosphere-derived neurons were fixed in 2% PFA for 30 min at room temperature. Cells were blocked and permeabilized at room temperature for 30 min. Differentiated neurons were stained at room temperature for 150 min with anti-TUBB3 (TUJ1; Covance). Neuronal organoids were sequentially incubated at room temperature in the dark for 30 min with Alexa Fluor 488 goat anti-mouse antibody (Invitrogen) and then counterstained for 5 min with DAPI. Samples were mounted in Mowiol and were acquired on a Zeiss LSM710 confocal microscope using Plan Apochromat 20×/0.8 M27 objective and EC Plan-Neofluar 40×/1.30 and Plan-Apochromat 63×/1.4 oil immersion objectives. Statistics. Results are shown as mean ± s.e.m. Statistical analysis was performed with GraphPad Prism software (GraphPad Software). Student's t-test was performed on homoscedastic populations. Unpaired t-test was applied on samples with different variances. Results were considered significant at *P < 0.05, **P < 0.01, ***P < 0.001. Data availability. The data that support the findings of this study are available on request from the corresponding author (H.V.-F.). The data are not publicly available due to patent application request. 
Replication
Describe whether the experimental findings were reliably reproduced. The experimental findings were reliably reproduced
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomization was performed. Animals were compared with cohoused control litter-mate controls
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was performed for experiments in Fig.4c Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Results are shown as mean ± s.e.m. Statistical analysis was performed with GraphPad Prism software (GraphPad Software, version 6, La Jolla, Calif).
